Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Joan C. Domingo"'
Autor:
Maricel Gómez-Soler, Begoña Cordobilla, Xavier Morató, Víctor Fernández-Dueñas, Joan C. Domingo, Francisco Ciruela
Publikováno v:
Frontiers in Neuroscience, Vol 12 (2018)
Parkinson’s disease (PD) is a neurodegenerative disorder of unknown etiology. The main treatment of PD consists of medication with dopamine-based drugs, which palliate the symptoms but may produce adverse effects after chronic administration. Accor
Externí odkaz:
https://doaj.org/article/17c0649f6f8740c7801889bdb9717075
Autor:
Pere Domingo, María Gracia Mateo, Joan Villarroya, Rubén Cereijo, Ferran Torres, Joan C. Domingo, Laura Campderrós, José M. Gallego-Escuredo, María del Mar Gutierrez, Isabel Mur, Noemí Corbacho, Francesc Vidal, Francesc Villarroya, Marta Giralt
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Journal of Clinical Medicine
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Journal of Clinical Medicine; Volume 11; Issue 3; Pages: 549
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Universidad de las Islas Baleares
Journal of Clinical Medicine, Vol 11, Iss 549, p 549 (2022)
Universidad de Barcelona
Journal of Clinical Medicine
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Journal of Clinical Medicine; Volume 11; Issue 3; Pages: 549
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Universidad de las Islas Baleares
Journal of Clinical Medicine, Vol 11, Iss 549, p 549 (2022)
Objective: People living with HIV (PLWH) have an increased cardiovascular risk (CVR) owing to dyslipidemia, insulin resistance, metabolic syndrome, and HIV/combination antiretroviral therapy (cART)-associated lipodystrophy (HALS). Atherosclerosis and
Aging is associated with increased FGF21 levels but unaltered FGF21 responsiveness in adipose tissue
Autor:
Joan, Villarroya, José M, Gallego-Escuredo, Alejando, Delgado-Anglés, Montserrat, Cairó, Ricardo, Moure, Ma, Gracia Mateo, Joan C, Domingo, Pere, Domingo, Marta, Giralt, Francesc, Villarroya
Publikováno v:
Aging Cell
Fibroblast growth factor 21 (FGF21) has been proposed to be an antiaging hormone on the basis of experimental studies in rodent models. However, circulating FGF21 levels are increased with aging in rodents and humans. Moreover, despite the metabolic